Skip to main content
. 2024 Dec 1;24(6):1785–1794. doi: 10.17305/bb.2024.10512

Figure S2.

Figure S2.

Kaplan–Meier overall survival estimate according to tyrosine kinase inhibitor response (long-term vs short-term) in all patients. PFS: Progression-free survival.